Main Timeline Video Share
May the Holiday Warm Hearts: Idram and IDBank Support the Children of Heroes Beneficiaries of the "By Your Side" program at IDBank AraratBank Named Large CSR Company of the Year Idram Joins the Fight Against Food Insecurity Ucom’s Renovated Sales and Service Center in Yerevan Mall Reopens 1% idcoin instead of New Year’s suffering: practical tips Idram Junior Donated Books to Schools Big Christmas Market with Idram, IDBank and idplus Ucom Supports Wildlife Monitoring in Ararat Region IDBank, Idram, and idplus at the Big Christmas Market Converse Bank Deputy CEO and CFO, Grant Akopian, Elected to BACEE Board Ucom and SunChild NGO Install a Solar Plant in Alaverdi Kindergarten
The Widely Discussed Dvin Crown Project. A New Visibility Platform for Brands Has Emerged in the Heart of YerevanAmeriabank named Most Innovative Digital Bank in Armenia, alongside 9 Global Finance Digital Banking AwardsUnibank and Picsart Academy Host Kids Day for ChildrenUnibank Issues AMD and USD Bonds with Annual Coupon Rates of 10.3% and 6%Artur Hovhannisyan and the Ambassador of Bulgaria to Armenia discussed a number of programs of mutual interest to Armenia and Bulgaria A new and fantastic story was born in the heart of Yerevan—the spirit of the old city at Hayasa Hotel Old YerevanConverse Bank is Lead Sponsor of the BACEE International Banking Conference Ralph Yirikian on the Cost of Digital Transformation at the 13th Regional HR Conference You Can Now Pay with Idram on Glovo: The Long-Awaited Partnership Is Now a RealityRate.Trading: Currency Exchange on a New Digital PlatformIdram's "City of Good Deeds": From Teamwork to Real Charitable Projects Ucom and FAST Bring Together Artificial Intelligence and Green Innovation From Car Selection to Purchase – All in One Place: Ameriabank to Present its Myar.am Platform and Special Offers at Armenian Auto Show IDBank and the “Dekavva Fund” Stand with People from Artsakh Ucom Supports AI-Powered Camera Installation for Nature Conservation Dmitry Ishkhanov Opens the New Steinway’s Concert Life in Pardubice Ucom Fellowship Participants Meet Ralph Yirikian at UcomUnibank Becomes Title Sponsor of Alashkert Football ClubSergey Smbatyan’s Music for Future Foundation and the Lang Lang International Music Foundation Invite Young Pianists to Apply for the Prestigious Lang Lang Young Scholars ProgramUnibank Call Center Now Available 24/7 on Weekdays
Life

1 in 4 people face side effects after getting COVID-19 vaccine

One in four people experiences side effects after being vaccinated against coronavirus. These are mostly minor side effects like pain at the injection site or headache, Lancet Infectious Diseases reported.

Analysis of data from the ZOE COVID Symptom Study, conducted by researchers at King's College London, found that side effects in the general population after vaccination with Pfizer and AstraZeneca were much lower than those reported in the trials.

The study also reported a significant reduction in infection rates from 12 to 21 days after the first dose of Pfizer (58% reduction) and AstraZeneca (39% reduction) compared to controls. The reduction in infection at least 21 days after the first dose is 69% for Pfizer and 60% for AstraZeneca.

Research has shown that:

  • 25.4% of vaccinated people reported one or more systemic side effects, while 66.2% reported one or more local side effects.
  • 13.5% of participants reported side effects after the first dose of Pfizer, 22.0% after the second dose of Pfizer, and 33.7% after the first dose of AstraZeneca.
  • The most common systemic side effect was a headache. 7.8% of people reported headaches after the first dose of Pfizer and 13.2% after the second dose of Pfizer. 22.8% of people who received the first dose of the AstraZeneca vaccine reported headaches.
  • The second most common systemic side effect was fatigue. 8.4% and 14.4% of participants reported fatigue after the first and second doses of the Pfizer vaccine, and 21.1% reported fatigue after the first dose of the AstraZeneca vaccine.
  • The most common localized side effect was soreness: 57.2% and 50.9% after the first and second doses of Pfizer vaccine and 49.3% after the first dose of AstraZeneca vaccine.

Side effects were more common in people under the age of 55 and in women.